UNSPSC 51332500: Antipsychotic butyrophenones

Antipsychotic drugs made from compounds containing phenyl-1-butanone.

UNSPSC 51332500 Antipsychotic butyrophenones is a Class code that presents a significant mismatch between its nominal scope and recent state and local procurement activity. The code's title refers to a specific class of antipsychotic medications, yet the three most recent opportunities tagged to it involve naloxone procurement, direct-to-manufacturer pharmacy initiatives, and generic multi-source pharmaceutical and OTC product supply — none of which fall within the antipsychotic butyrophenone category. State and local governments are using this code to solicit broader pharmaceutical supply, distribution, and pharmacy benefit management services rather than the specific drug class the code nominally describes, suggesting either systematic miscoding or a state procurement system that collapses multiple pharmaceutical procurement categories under a single taxonomy entry.

The issuing bodies span multiple jurisdictions: Seminole County, Florida (an IFB for naloxone and drug deactivation systems with a July 26, 2023 response date); the Texas Health and Human Services Commission (an RFI for direct-to-manufacturer prescription programs posted April 3, 2026); and the Minnesota Multistate Cooperative Purchasing Alliance administered by the Minnesota Department of Administration, covering multi-state pharmaceutical procurement with an RFP response deadline of March 26, 2026. Recent activity is concentrated in Florida, Texas, and Minnesota, with the MMCAP cooperative extending to Oregon. The code shows activity across state health agencies, county health departments, and cooperative purchasing vehicles, but the pharmaceutical product and service categories represented — emergency response supplies, pharmacy benefit redesign, and generic drug distribution — do not align with antipsychotic butyrophenone procurement. Business development professionals evaluating opportunities under this code should verify that opportunities tagged here match their actual service or product lines before investing pursuit effort, as the recent record suggests inconsistent or overly broad classification.